WHAT IS DELSTRIGO?
+

DELSTRIGO is a complete, one-pill prescription HIV medicine used to treat human immunodeficiency virus-1 (HIV-1) infection in adults who have not taken HIV-1 medicines before. HIV is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).

 

Think Differently About Your HIV-1 Treatment
Think Differently About Your HIV-1 Treatment

HIV-1 AND YOUR HEALTH

THE STORY DOESN’T END AT UNDETECTABLE
THE STORY DOESN’T END AT UNDETECTABLE

Getting to undetectable is important—it means the level of HIV in your blood is so low that lab tests can’t find it. But when you and your doctor talk about treatment options for HIV, it’s also important to consider things beyond viral load suppression, like drug-drug interactions and side effects.

Start thinking about the bigger picture and talk to your doctor about DELSTRIGO.

HIV-1 and Your Health: The Story Doesn't End at an Undetectable Viral Load
Ask Your Doctor If DELSTRIGO™ (doravirine/lamivudine/tenofovir disoproxil fumarate) Is Right for YouFind Out How Eligible Patients May Be Able to Save on DELSTRIGO™ (doravirine/lamivudine/tenofovir disoproxil fumarate)
Ask Your Doctor If DELSTRIGO™ (doravirine/lamivudine/tenofovir disoproxil fumarate) Is Right for YouFind Out How Eligible Patients May Be Able to Save on DELSTRIGO™ (doravirine/lamivudine/tenofovir disoproxil fumarate)
LOOKING TO LOWER YOUR OUT-OF-POCKET COSTS FOR DELSTRIGO?

You may be able to take advantage of prescription savings on DELSTRIGO.

SAVINGS COUPON

Eligible, privately insured patients may pay as little as $0 up to a total program savings of $6,800. Not all patients are eligible and certain restrictions apply. Please see Terms and Conditions to find out if you can save.

FREE TRIAL OFFER FOR DELSTRIGO

Eligible patients may receive up to a 30-tablet supply of DELSTRIGO. Not all patients are eligible. Certain restrictions apply. Please see Terms and Conditions.


 

 
TRUSTe Verified Privacy TRUSTe APEC Privacy

Copyright © 2019 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.

For United States, its territories, and Puerto Rico only. US-DOR-00181 09/19

Worsening of hepatitis B virus infection (HBV). If you have both HIV-1 and HBV and stop taking DELSTRIGO, your HBV may suddenly get worse. Do not stop taking DELSTRIGO without first talking to your healthcare provider, as they will need to monitor your health. Your doctor should test you for HBV infection before you start treatment with DELSTRIGO.